Journal of Vaccine Research 2024, Vol.14, No.6, 316-323 http://medscipublisher.com/index.php/jvr 320 Figure 2 Mechanism of immune activation by mRNA-LNPs vaccine (Adopted from Fayez et al., 2023) 6.3 Applications of AI and big data in vaccine research and development Artificial intelligence and big data analysis are revolutionizing vaccine research and development science in identifying potential vaccine targets and optimizing vaccine design by rapidly screening vast amounts of data. Artificial intelligence algorithms are acquiring the capability to predict the ideal mRNA sequence that can trigger a strong immune response, thus accelerating the process of vaccine development. In addition, analysis of big data enables real-time monitoring of the safety and effectiveness of vaccines, allowing a basis for continuous optimization of mRNA vaccine composition (Fayez et al., 2023). All of these technologies were instrumental to the rapid development and launch of mRNA vaccines during the COVID-19 pandemic and demonstrated its vast potential in vaccine research and development in the future. 7 Future Directions of mRNA Technology 7.1 Prospects for developing multifunctional and broad-spectrum vaccines mRNA technology is highly promising for the development of multifunctional and broad-spectrum vaccines. By designing mRNA vaccines encoding multiple antigens, it is feasible to treat multiple pathogens simultaneously, which is particularly crucial for the co-infection of prevalent infectious diseases. Additionally, the convenience of adapting mRNA technology to newly emerged pathogens renders it an effective tool to boost pandemic prevention and control (Zhang et al., 2019). At the same time, since mRNA vaccines can induce cellular and humoral immunity without being restricted by MHC haplotypes, their broad-spectrum efficacy has also been complemented (Feng et al., 2024). 7.2 Potential for personalized medicine and tailored vaccines mRNA technology has shown broad prospects in personalized medicine, and one of the most visible fields is oncology. Personalized mRNA vaccines can be designed according to the patient's status and encode tumor-specific antigens, thereby triggering a specific immune response against the tumor cells. The approach has shown encouraging preclinical and early clinical data, with the possibility of tailoring the vaccines to an individual's unique genetic makeup. mRNA vaccine's fast and flexible manufacturing characteristic enables it to be adapted quickly to the particular genetic composition of single patients, paving the path for the final personalized treatment strategies (Kowalczyk et al., 2016). 7.3 Strategies for global health equity and vaccine accessibility Making the world more equitable in health and making vaccines more accessible is one of the significant issues that mRNA technology must address. The production process of mRNA vaccines, being inexpensive and synthetic in nature, is easy to mass-produce, which is needed to meet the world demand (Pardi et al., 2018). Apart from this, with optimization of technology, its ease of storage and stability will be improved even more, hence distribution within the regions that lack resources will become simpler. Currently, research is ongoing to increase the stability and delivery effectiveness of mRNA vaccines to make the vaccine more readily available to those in developing countries. Collaboration between government, international agency and company is necessary to ensure that the benefits of mRNA vaccines are shared equally across the world.
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==